Urticaria (Chronic) - Causes, Treatment & When to See a Doctor

```html

What is Urticaria (Chronic)?

Urticaria, commonly known as hives, is a skin reaction that produces raised, red or flesh‑colored welts that itch, burn, or sting. When these welts appear repeatedly for six weeks or longer, the condition is called **chronic urticaria (CU)**. Unlike an acute allergic rash that typically resolves within a few days, chronic urticaria persists, often flaring and subsiding over months or years. The lesions are usually transient—each individual hive lasts less than 24 hours—but new hives continue to develop in other areas of the body.

CU affects about 0.5‑1 % of the general population and is more common in women than men. While it can be unsettling, most cases are not life‑threatening. Understanding the underlying triggers, associated symptoms, and treatment options helps patients regain control and improve quality of life.

Common Causes

In many people, chronic urticaria is **idiopathic**, meaning no specific cause can be identified. However, research identifies several categories of triggers that can provoke or amplify the condition. Below are the most frequently reported causes:

• Autoimmune disease – About 30‑45 % of CU cases are autoimmune, where the body produces antibodies that mistakenly activate mast cells.
• Infections – Chronic viral (e.g., hepatitis C, HIV), bacterial (e.g., Helicobacter pylori), or fungal infections can sustain inflammation.
• Medications – NSAIDs, antibiotics (especially penicillins and cephalosporins), and ACE inhibitors are common culprits.
• Physical stimuli – Pressure, cold, heat, sunlight, vibration, or water can trigger “physical urticaria.”
• Hormonal changes – Fluctuations during the menstrual cycle, pregnancy, or thyroid disorders may worsen hives.
• Food additives – Preservatives (e.g., sulfites), artificial colors, and high‑histamine foods can exacerbate symptoms in sensitive individuals.
• Autoantibodies against IgE receptor – Known as “type IIb” autoimmune urticaria, these antibodies directly activate mast cells.
• Underlying systemic diseases – Lupus, rheumatoid arthritis, and celiac disease have been linked to chronic urticaria.
• Stress and emotional factors – While not a direct cause, stress can amplify the immune response and trigger flare‑ups.
• Idiopathic – In up to 50 % of patients, no identifiable trigger is found despite thorough evaluation.

Associated Symptoms

Chronic urticaria may occur alone, but it often co‑exists with other complaints that provide clues about the underlying mechanism:

• Intense itching (pruritus) that worsens at night.
• Swelling (angio‑edema) of the lips, eyelids, hands, or feet.
• Burning or stinging sensation under the hive.
• Headache, fatigue, or a general sense of “malaise.”
• Joint or muscle aches—more typical when an autoimmune disease is present.
• Gastro‑intestinal symptoms (bloating, abdominal pain) if food‑related triggers exist.
• Respiratory symptoms (nasal congestion, mild wheeze) in patients with concomitant allergic rhinitis or asthma.

When to See a Doctor

Because chronic urticaria can affect daily activities and occasionally signal a more serious condition, it’s important to seek medical attention promptly if you notice any of the following:

• Hives that persist for more than six weeks.
• Swelling that involves the face, lips, tongue, or throat (possible angio‑edema).
• Difficulty breathing, wheezing, or tightness in the chest.
• Rapid spreading of hives after a new medication or food is introduced.
• Symptoms accompanied by fever, joint pain, or a rash that looks like bruising.
• Persistent itching that disrupts sleep or daily activities.
• Any suspicion that your hives are related to an underlying autoimmune or systemic disease.

Diagnosis

Diagnosing chronic urticaria involves a stepwise approach that combines a thorough history, physical examination, and targeted investigations.

1. Detailed Medical History

• Onset, duration, and pattern of hives.
• Potential triggers (foods, drugs, environmental exposures, stress).
• Associated symptoms (angio‑edema, systemic complaints).
• Family history of allergies or autoimmune disease.

2. Physical Examination

• Inspection of skin lesions—size, shape, distribution, and whether they fade within 24 hours.
• Evaluation for angio‑edema and for signs of systemic disease (e.g., joint swelling, thyroid enlargement).

3. Laboratory Tests (when indicated)

• Complete blood count (CBC) – to rule out eosinophilia or infection.
• Serum thyroid‑stimulating hormone (TSH) – hypothyroidism is linked to CU.
• Autoimmune panel (ANA, anti‑thyroid antibodies) if autoimmune urticaria is suspected.
• Helicobacter pylori stool antigen or breath test if gastrointestinal symptoms are present.
• Specific IgE or skin prick testing – useful when a food or inhalant allergy is suspected.

4. Specialized Tests

• Autologous serum skin test (ASST) – injects the patient’s own serum intradermally to detect autoantibodies.
• Physical challenge tests – applying cold, heat, pressure, or vibration to provoke hives under medical supervision.

The goal of testing is not to identify every possible trigger (which is often impossible) but to rule out treatable underlying conditions and to guide therapy.

Treatment Options

Therapy for chronic urticaria follows a stepwise algorithm recommended by the American Academy of Dermatology (AAD) and European guidelines. The main aim is to control symptoms, improve quality of life, and identify/remedy any underlying cause.

1. First‑Line: Non‑Sedating Antihistamines

• Second‑generation H1‑antihistamines (cetirizine, loratadine, fexofenadine, desloratadine, levocetirizine) are preferred because they cause minimal drowsiness.
• Standard dose is taken once daily; if control is insufficient after 2 weeks, the dose can be increased up to fourfold under physician guidance (e.g., cetirizine 20 mg).

2. Second‑Line: Add‑On Therapies

• H2‑antagonists (ranitidine, famotidine) added at bedtime can augment H1 blockade.
• Leukotriene receptor antagonists (montelukast) may help especially in aspirin‑exacerbated urticaria.

3. Third‑Line: Omalizumab (Anti‑IgE)

• Subcutaneous injection of 300 mg every 4 weeks has shown >80 % response rates in refractory CU.
• Generally well‑tolerated; monitoring for injection‑site reactions and rare anaphylaxis is required.

4. Fourth‑Line: Immunosuppressants

• Low‑dose oral corticosteroids (e.g., prednisone ≤10 mg daily) can be used for short‑term bursts (<2 weeks) to break severe flares.
• For steroid‑dependent disease, agents such as cyclosporine, methotrexate, or mycophenolate mofetil may be considered under specialist care.

5. Symptomatic & Home Measures

• Cool compresses or wet cloths on affected areas provide relief.
• Baths with colloidal oatmeal or baking soda can soothe itching.
• Avoid known triggers (e.g., NSAIDs, tight clothing, extreme temperatures).
• Maintain a symptom diary to identify patterns.
• Stress‑reduction techniques—mindfulness, yoga, or counseling—may lessen flare‑ups.

6. Patient Education

• Explain that each hive typically resolves within 24 hours, even without treatment.
• Reassure patients that most chronic urticaria is not a sign of an impending allergic shock, but that angio‑edema warrants vigilance.

Prevention Tips

While chronic urticaria cannot always be prevented, several practical steps can reduce the frequency and severity of flares:

• Identify and eliminate triggers – use a diary to note foods, medications, or activities that precede hives.
• Medication review – ask your doctor about alternatives to NSAIDs or aspirin if you notice a correlation.
• Skin care – wear loose, cotton clothing; avoid tight belts or jewelry that may cause pressure urticaria.
• Temperature control – keep environments moderate; use cool showers in hot weather and avoid sudden cold exposure.
• Manage underlying conditions – treat hypothyroidism, Helicobacter infection, or autoimmune disease promptly.
• Stress management – regular exercise, adequate sleep, and relaxation techniques help keep the immune system balanced.
• Limit alcohol and hot beverages – these can dilate blood vessels and worsen itching for some patients.
• Vaccinations – stay up to date; certain infections can trigger or worsen CU.

Emergency Warning Signs

Key Takeaways

• Chronic urticaria is defined by hives that persist for ≥ 6 weeks.
• Most cases are idiopathic, but autoimmune disease, infections, medications, and physical triggers are common contributors.
• First‑line treatment is non‑sedating antihistamines, with escalation to omalizumab or immunosuppressants for refractory disease.
• Keeping a symptom diary, avoiding known triggers, and managing stress can markedly reduce flare‑ups.
• Watch for angio‑edema or breathing difficulties—these are emergencies that require immediate care.

For personalized advice and to discuss the most appropriate treatment plan, schedule an appointment with a dermatologist or allergy/immunology specialist.

---

References:

1. Mayo Clinic. Urticaria (hives). 2023. Link.
2. American Academy of Dermatology. Guidelines of care for the management of chronic urticaria. 2022.
3. National Institute of Allergy and Infectious Diseases (NIAID). Chronic Urticaria. 2021.
4. European Academy of Allergy and Clinical Immunology. EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. 2023.
5. Cleveland Clinic. Hives (Urticaria). 2024. Link.

```